57266-70-3 Usage
Uses
Used in Organic Synthesis:
3,6-Pyridazinedicarboxylic acid is used as a building block in the synthesis of various organic compounds. Its unique structure allows for the formation of a wide range of derivatives, making it a valuable component in the development of new chemical entities.
Used in Receptor Sensitive Materials:
3,6-PYRIDAZINEDICARBOXYLIC ACID is utilized in the creation of materials that are sensitive to the presence of specific receptors. Its chemical properties enable it to interact with these receptors, allowing for the detection and monitoring of their activity in various applications.
Used in Pharmaceutical Intermediates:
3,6-Pyridazinedicarboxylic acid serves as an intermediate in the production of pharmaceuticals. Its presence in the synthesis process contributes to the development of new drugs and medications, potentially leading to advancements in the field of medicine.
Used in Chemical Research:
3,6-PYRIDAZINEDICARBOXYLIC ACID is employed in various chemical research areas, where its properties and reactions are studied to gain a deeper understanding of its potential applications and interactions with other chemical entities. This research can lead to the discovery of new uses and applications for 3,6-Pyridazinedicarboxylic acid in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 57266-70-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,6 and 6 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 57266-70:
(7*5)+(6*7)+(5*2)+(4*6)+(3*6)+(2*7)+(1*0)=143
143 % 10 = 3
So 57266-70-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H4N2O4/c9-5(10)3-1-2-4(6(11)12)8-7-3/h1-2H,(H,9,10)(H,11,12)
57266-70-3Relevant academic research and scientific papers
BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING SAME
-
, (2019/06/05)
Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1 ), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.
New Syntheses of Polyaza Derivatives. Crystal Structure of Pyridazine-3,6-dicarboxylic Acid
Sueur, Stephane,Lagrenee, Michel,Abraham, Francis,Bremard, Claude
, p. 1285 - 1289 (2007/10/02)
A new route allowing the synthesis of pyridazine-3,6-dicarboxylic acid in preparative quantities is described.The crystal structure of this compound is reported.Several polyaza derivatives were prepared and their structures determined by spectroscopic methods (ir, 1H and 13C nmr).
